Panacea Biotec, US’s Bionpharma join hands for 7 drugs

By: |
New Delhi | Published: July 28, 2017 12:46:49 PM

Drug firm Panacea Biotec today said it has entered into a joint collaboration with the US's Bionpharma for development, licence, manufacturing, supply and sales of seven complex generic products.

Panacea Biotec,Bionpharmadrug companies,  ANDA, US's Bionpharma, US market, BSE filing,  licence and supply agreementPanacea Biotec said the joint collaboration is for commercialisation of seven abbreviated new drug applications under development, representing a total estimated market potential of more than USD 800 million (Rs 5,130 crore). (Reuters)

Drug firm Panacea Biotec today said it has entered into a joint collaboration with the US’s Bionpharma for development, licence, manufacturing, supply and sales of seven complex generic products. Panacea Biotec said the joint collaboration is for commercialisation of seven abbreviated new drug applications under development, representing a total estimated market potential of more than USD 800 million (Rs 5,130 crore). Under the collaboration, Panacea will be responsible for development, filing, registration, manufacturing and supply of these ANDAs, it said in a BSE filing.

Bionpharma will be responsible for importation, warehousing, sales and distribution of these ANDAs in the US and its territories. Under a previous arrangement, Bionpharma is also the exclusive distributor for company’s 2 ANDAs in the US market. These ANDAs have already been commercialised under a separate exclusive licence and supply agreement. Shares of Panacea Biotec were trading 4.93 per cent higher at Rs 141.50 apiece on BSE.

 

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Next Stories
1Axis Bank buys payment wallets Freecharge for Rs 385 cr in all cash deal
2Reliance Communications looks to avoid action in NCLT, seeks time for Aircell merger, tower business sale
3Reliance Jio Phone to drive VoLTE devices numbers to 500 mn as India set to take to new feature phone